Merck : MRK

All Merck Articles

1088 Articles

Jon C. Ogg | Sep 25, 2013 at 9:40 AM EDT

Short Sellers Pile On and Attack High-Yield Dividend Stocks

ThinkstockShort sellers have increased their bets against the stable high-dividend stocks that are in most Americans’ retirement accounts and mutual…

Jon C. Ogg | Sep 10, 2013 at 12:20 PM EDT

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Wikimedia CommonsChances are high that you already have heard that the Dow Jones Industrial Average (DJIA) is making a serious change…

Jon C. Ogg | Aug 12, 2013 at 10:25 AM EDT

Short Sellers Get Schizo Regarding High-Yield Dividends: AEP, GE, Annaly, Altria and More

Jon OggShort sellers are trying to decide what to do when it comes to how evaluate the high-yield dividend and…

Jon C. Ogg | Aug 12, 2013 at 9:20 AM EDT

Merck Temodar Gets Generic Competition in Brain Cancer

ThinkstockMerck & Co. Inc. (NYSE: MRK) is seeing one more drug drive off the patent cliff. News was released on…

Jon C. Ogg | Aug 5, 2013 at 8:30 AM EDT

Ten Companies Buying Back Huge Amounts of Their Own Stock

courtesy of Wal-Mart Stores Inc.Companies can return capital to shareholders in many ways. Dividends are one of the favored methods.…

Jon C. Ogg | Jul 25, 2013 at 9:35 AM EDT

Short Sellers Make Big Changes in High-Yield Dividend Stocks

ThinkstockShort sellers are continuing to keep their bets against many of the top defensive high-yield dividend stocks. Increased volatility in…

Jon C. Ogg | Jul 11, 2013 at 11:15 AM EDT

Short Sellers Make Big Changes in High-Yield Dividend Stocks: AEP, Altria, Annaly and More

Short sellers are continuing to keep their bets against many of the top defensive high-yield dividend stocks. Increased volatility in…

Paul Ausick | Jul 2, 2013 at 7:35 AM EDT

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a…

Jon C. Ogg | Jun 26, 2013 at 11:25 AM EDT

Short Sellers Are Tactical in Top High-Yield Dividend Stocks

Short sellers have really made some big changes in their bets against the key high-yield dividend stocks that had been…

Jon C. Ogg | Jun 12, 2013 at 9:30 AM EDT

Short Sellers Missed the Boat in Top High Dividend Stocks

Short sellers could have cleaned up by betting against the high dividend stocks in May and into June. Investors got…

Jon C. Ogg | Jun 8, 2013 at 7:45 AM EDT

Top Analyst Calls of the Week, Stocks to Buy, Stocks to Sell, Sector by Sector

This last week had much more volatility than what investors have grown used to. 24/7 Wall St. wanted to highlight…

Jon C. Ogg | Jun 6, 2013 at 8:00 AM EDT

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum…

Paul Ausick | Jun 3, 2013 at 4:04 PM EDT

Closing Bell for Monday on Wall Street: Markets Wobble, But Finish Higher today

U.S. equity markets opened higher this morning following a slightly upbeat report on eurozone manufacturing PMI. While not yet in…

Jon C. Ogg | May 31, 2013 at 2:22 PM EDT

Rising Interest Rate Risk For Big Dividends, Sector By Sector

The bull market appears to still be alive and well for equities, but the risk of rising interest rates is…

Jon C. Ogg | May 28, 2013 at 10:15 AM EDT

Short Sellers Become Tactical in the Top High-Yield Dividend Stocks

ThinkstockShort sellers are have previously been all over the place when it comes to the high-yield dividend stocks. The May 15…

1 … 52 53 54 55 56 … 73

Merck : MRK

All Merck Articles

Short Sellers Pile On and Attack High-Yield Dividend Stocks

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Short Sellers Get Schizo Regarding High-Yield Dividends: AEP, GE, Annaly, Altria and More

Merck Temodar Gets Generic Competition in Brain Cancer

Ten Companies Buying Back Huge Amounts of Their Own Stock

Short Sellers Make Big Changes in High-Yield Dividend Stocks

Short Sellers Make Big Changes in High-Yield Dividend Stocks: AEP, Altria, Annaly and More

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Short Sellers Are Tactical in Top High-Yield Dividend Stocks

Short Sellers Missed the Boat in Top High Dividend Stocks

Top Analyst Calls of the Week, Stocks to Buy, Stocks to Sell, Sector by Sector

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

Closing Bell for Monday on Wall Street: Markets Wobble, But Finish Higher today

Rising Interest Rate Risk For Big Dividends, Sector By Sector

Short Sellers Become Tactical in the Top High-Yield Dividend Stocks

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here’s How to Retire There at 62 Without Touching Your Savings

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here's How to Retire There at 62 Without Touching Your Savings

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

Merck : MRK

All Merck Articles

Short Sellers Pile On and Attack High-Yield Dividend Stocks

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Short Sellers Get Schizo Regarding High-Yield Dividends: AEP, GE, Annaly, Altria and More

Merck Temodar Gets Generic Competition in Brain Cancer

Ten Companies Buying Back Huge Amounts of Their Own Stock

Short Sellers Make Big Changes in High-Yield Dividend Stocks

Short Sellers Make Big Changes in High-Yield Dividend Stocks: AEP, Altria, Annaly and More

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Short Sellers Are Tactical in Top High-Yield Dividend Stocks

Short Sellers Missed the Boat in Top High Dividend Stocks

Top Analyst Calls of the Week, Stocks to Buy, Stocks to Sell, Sector by Sector

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

Closing Bell for Monday on Wall Street: Markets Wobble, But Finish Higher today

Rising Interest Rate Risk For Big Dividends, Sector By Sector

Short Sellers Become Tactical in the Top High-Yield Dividend Stocks

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here’s How to Retire There at 62 Without Touching Your Savings

Featured Reads

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here's How to Retire There at 62 Without Touching Your Savings